Claus Cursiefen
Corporate Officer/Principal bei Cologne University of Applied Sciences
Profil
Dr. Claus Cursiefen, MD, is Chairman-Ophthalmology Department at Cologne University of Applied Sciences and an Associate Scientist at Harvard Medical School.
He is on the Board of Directors at Novaliq GmbH.
Aktive Positionen von Claus Cursiefen
| Unternehmen | Position | Beginn |
|---|---|---|
| Cologne University of Applied Sciences | Corporate Officer/Principal | - |
| Harvard Medical School | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Claus Cursiefen
| Unternehmen | Position | Ende |
|---|---|---|
Novaliq GmbH
 Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Novaliq GmbH
Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Health Technology |
